Kronos Bio Total Assets

Kronos Bio posts a total assets of $110M as of March 2025. That compares with $180M in the prior-year period — down 40.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Kronos Bio's total assets was $180M. The latest reading is $110M — a 40.9% year-over-year decrease (period ending March 2025). Use the history and growth charts on this page for a longer lookback.

Total Assets is one piece of Kronos Bio's financial statement story. At $110M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for KRON's total assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Kronos Bio's other metric pages and overview cover the third.

Judging Kronos Bio against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in total assets easier to interpret. Start with $110M here, then scan peer and history charts to see if the gap is persistent.